摘要:
The invention relates to a salt of risperidone in solid state having a water solubility of at least 10 mg/ml, to risperidone dihydrochloride, risperidone hydrogenmaleate, risperidone hernitartrate and risperidone (L)-hemimalate, to a process for making a solid state water soluble salt of risperidone, which comprises: contacting a risperidone donor with a suitable acid in an organic solvent to form a water soluble risperidone salt; and precipitating said risperidone salt from said solvent, and to the use for treating psychotic disorders in a mammal.
摘要:
A process for making montelukast, a pharmaceutically useful compound of the following formula and salts thereof: formula (1), using a compound of formula (20) and a compound of formula (5) is provided.
摘要:
A process for making montelukast, a pharmaceutically useful compound of the following formula and salts thereof: formula (1), using a compound of formula (20) and a compound of formula (5) is provided.
摘要:
The present invention relates to an improved process for making anagrelide of formula (1), or an acid addition salt thereof, including any hydrated or solvated form thereof, comprising reacting a compound of formula (3), or an acid addition salt thereof, (3), wherein R is a C1-C4 alkyl group, with chloroformamidine hydrochloride of formula (8), in an inert solvent, followed by treatment of the reaction mixture with a base.
摘要:
A process for making montelukast, a pharmaceutically useful compound of the following formula and salts thereof: formula (1), using a compound of formula (4), is provided.
摘要:
Hydrochloride salts of risperidone have been found to have useful properties. A preferred form is crystalline risperidone monohydrochloride hemipentahydrate. The monohydrochloride salts can be used in pharmaceutical compositions and methods such as for use in treating psychotic disorders.